↓ Skip to main content

Cochrane Database of Systematic Reviews

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients

Overview of attention for article published in Cochrane database of systematic reviews, June 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
155 Mendeley
citeulike
1 CiteULike
Title
Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients
Published in
Cochrane database of systematic reviews, June 2014
DOI 10.1002/14651858.cd009120.pub2
Pubmed ID
Authors

Ling Zhang, Xiaoxi Zeng, Ping Fu, Hong Mei Wu

Abstract

Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) are widely used in peritoneal dialysis (PD) patients, yet controversy exists about their impact on residual kidney function.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ecuador 1 <1%
Brunei Darussalam 1 <1%
Canada 1 <1%
Unknown 152 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 14%
Researcher 18 12%
Student > Ph. D. Student 16 10%
Student > Bachelor 15 10%
Student > Postgraduate 10 6%
Other 33 21%
Unknown 41 26%
Readers by discipline Count As %
Medicine and Dentistry 61 39%
Nursing and Health Professions 16 10%
Economics, Econometrics and Finance 5 3%
Agricultural and Biological Sciences 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 17 11%
Unknown 48 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2020.
All research outputs
#7,993,771
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,729
of 11,842 outputs
Outputs of similar age
#72,786
of 243,425 outputs
Outputs of similar age from Cochrane database of systematic reviews
#177
of 239 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,425 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.